November 8, 2013
WASHINGTON –– Speaking at the U.S. News & World Report Hospital of Tomorrow forum Tuesday, Northrop Grumman Corporation's (NYSE:NOC) Amy Caro, vice president of health IT programs, said advances in genomics and more widespread use of molecular data will enhance healthcare and improve health outcomes but ensuring the security of personal data is key to [...]
Implant Sciences’ QS-B220 Explosives Trace Detector Receives
November 7, 2013
WILMINGTON, Mass.-- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the QS-B220 explosives and drugs trace detector has been issued a SAFETY Act Designation (as defined in Section 25.2 of the Regulations) from the Department of Homeland Security. The QS-H150 handheld [...]
MOCON Named Tenth Fastest Growing Public Company in Minnesota
November 7, 2013
MINNEAPOLIS -- MOCON, Inc. (NASDAQ:MOCO) announced today that on October 25, 2013, the Minneapolis/St. Paul Business Journal named MOCON, Inc. to its list of the top twenty-five fastest growing public companies in Minnesota. MOCON was ranked number ten on the list which assessed the companies by annualized three year revenue growth. MOCON’s average annual growth [...]
Dynasil Divests XRF Product Line
November 7, 2013
WATERTOWN, Mass. -- Dynasil Corporation of America (NASDAQ: DYSL), a developer of sensing, detection and analysis technology for homeland security, medical and industrial applications, today completed the sale of the assets of its X-Ray Florescence (XRF) Lead Paint Detector product line to PROTEC Instrument Corporation, the U.S. subsidiary of its long-time distributor, French firm Laboratories [...]
November 7, 2013
VANCOUVER – STEMCELL Technologies announced today that the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) will provide up to $1.5 million in financial support for the development of cell isolation technology that will further basic and translational HIV research as well as broader research in infectious disease. Despite significant progress in understanding [...]
Meridian Bioscience Reports Record Fourth Quarter and Full-Year Operating Results
November 7, 2013
CINCINNATI -- Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today: *reported record fourth quarter and full-year fiscal 2013 net sales of $49.0 million and $188.7 million, respectively, increases of 13% and 9%, respectively, from the same periods of the prior fiscal year; *reported record fourth quarter and full-year fiscal 2013 operating income of $13.3 million [...]
New Handheld Raman Spectrometer Provides Portable Pharmaceutical Analysis
November 7, 2013
TEWKSBURY, Mass. -- Pharmaceutical manufacturers and regulatory agencies around the world can use a new, cost-effective handheld Raman analyzer to quickly identify raw materials and confirm the authenticity of finished products. The Thermo Scientific TruScan GP offers pharmaceutical identification capabilities for pharmaceutical manufacturers in emerging markets. “Our objective is to provide reliable chemical identification to [...]
Accelrys Advances Biology Innovation with New Release of Assay and Study Management Product Suite
November 7, 2013
SAN DIEGO -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, has announced the latest release of its unified biology assay and study management software suite consisting of Accelrys BioRails DM 4.5, Accelrys BioRails PTO 4.5 and Accelrys Morphit 3.0. The Accelrys BioRails assay data management and project tracking/optimization applications [...]
Hamilton Storage Technologies – Gold Winner of MassEcon Economic Impact Award
November 7, 2013
Hamilton Storage Technologies has been named the Southeast Gold winner of the MassEcon Team Massachusetts Economic Impact Award, which celebrates companies that have made an outstanding contribution to the Massachusetts economy. MassEcon selected winners based on job growth, facility expansion, and investment since January 1, 2012, as well as other criteria including community involvement. Finalists [...]
November 7, 2013
CHARLOTTESVILLE, Va. -- Safer and more effective anticancer drugs may soon be developed thanks to a Small Business Innovation Research contract recently awarded to HemoShear by the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH). HemoShear, LLC, is the pharmaceutical industry's leading developer of the most advanced human biology systems for [...]

